, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03
. Financial Position As at December 31 Change 2019 2018 MB MB MB % Total assets 525.87 195.47 330.40 169.03 Total liabilities 60.13 88.48 (28.35) (32.04) Total shareholders’ equity 465.74 106.99 358.75 335.31
Baht) 2017 2016 Inc./(Dec.) % Current Assets 220.09 189.91 30.18 15.89 Non-Current Assets 273.02 278.47 -5.45 -1.96 Total Assets 493.11 468.38 24.73 5.28 Current Liabilities 285.67 243.80 41.87 17.17 Non
ccounts receiv ther long-term quipment otal non-curre otal Assets abilities and S hort-term loan stitutions rade and othe urrent portion hort-term loan otal current lia ong-term loans ebentures - ne otal
parts segment amounting to Baht 2,259 million. Financial Position Analysis (Unit : Million Baht) Year Year Change 2019 2018 Amount % Change Total Assets 21,246 17,891 3,355 18.75% Total Liabilities 13,766
liquidity for derivatives trading in derivatives exchange; (4) “ initial margin ” means the minimum amount of assets which a client shall deposit to secure the performance of derivatives when entering a
” means the minimum amount of assets which a client shall deposit to secure the performance of derivatives when entering a derivatives position; (5) “maintenance margin” means the minimum amount of assets
Tangible Assets (“NTA”) (NTA of the Company as per the latest financial statement as of 31 December 2018 was Baht 13,210.52 million) which is less than Baht 20 million or 3 percent of the Company’s Net
from December 31, 2018 as follows; Assets Total Liabilities & Shareholders' Equity Total Assets was Baht 3,223.29 million, decreased Baht 809.37 million or 20.07%, mostly from the decrease in current